csirt@kutim:~/threat-intel/cve/CVE-2022-23532

Katalog CVE

CVSS 6.5 · Medium EPSS 0,66%

Kerentanan Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') pada neo4j awesome procedures on cyper. Skor CVSS 3.1 6.5 (Medium) menurut NVD.

Deskripsi (NVD)

APOC (Awesome Procedures on Cypher) is an add-on library for Neo4j that provides hundreds of procedures and functions. A path traversal vulnerability found in the apoc.export.* procedures of apoc plugins in Neo4j Graph database. The issue allows a malicious actor to potentially break out of the expected directory. The vulnerability is such that files could only be created but not overwritten. For the vulnerability to be exploited, an attacker would need access to execute an arbitrary query, either by having access to an authenticated Neo4j client, or a Cypher injection vulnerability in an application. The minimum versions containing patch for this vulnerability are 4.4.0.12 and 4.3.0.12 and 5.3.1. As a workaround, you can control the allowlist of the procedures that can be used in your system, and/or turn off local file access by setting apoc.export.file.enabled=false.

Rincian

Terbit di NVD
14 Januari 2023
Terakhir diubah
17 Juni 2026
Status NVD
Modified
CVSS 3.1
6.5 (Medium), sumber NVD
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
EPSS (30 hari)
0,66% peluang dieksploitasi; lebih tinggi dari 50,1% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
neo4j awesome procedures on cyper Semua versi sebelum 4.3.0.12
neo4j awesome procedures on cyper Versi 4.4.0.0 hingga sebelum 4.4.0.12
neo4j awesome procedures on cyper Versi 5.3.0

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.